Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants

Phase: N/A Priority: Normal
NCT ID: NCT06752174 Org: User:
Start: 03/08/23 End: 04/12/24 Due: 04/12/25

A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04758273 Org: User:
Start: 10/07/20 End: 02/28/22 Due: 02/28/23

Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02003495 Org: User:
Start: 10/31/13 End: 10/31/14 Due: 10/31/15

A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years

Phase: N/A Priority: Normal
NCT ID: NCT06210737 Org: User:
Start: 09/26/19 End: 11/13/22 Due: 11/13/23

A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04756323 Org: User:
Start: 10/27/20 End: 02/28/22 Due: 02/28/23

Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried

Phase: N/A Priority: Normal
NCT ID: NCT02560272 Org: User:
Start: 09/30/14 End: 06/30/16 Due: 06/30/17

A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT06608199 Org: User:
Start: 11/01/24 End: 10/01/26 Due: 10/01/27

Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02003313 Org: User:
Start: 11/30/13 End: 07/31/15 Due: 07/31/16